I would repeat that as well. I think an important point is related to operational research. The money that Canada has contributed to the Global Fund is fantastic, but the problem remains that treatment is too difficult for most people to take. So we need to put some money into looking at drug-resistant TB treatment regimens that are more tolerable, that can be given in a number of months instead of a number of years. Also, as Helen mentioned, there need to be child-friendly formulations. Often it's children who suffer. When somebody has drug-resistant TB, their whole family or community is affected.
On March 24th, 2014. See this statement in context.